Wharton’s Jelly
The umbilical cord is largely composed of Wharton’s Jelly. A clear gelatinous The umbilical cord is largely composed of Wharton’s Jelly. A clear gelatinous substance, similar to the jelly inside our eyes, consisting mainly of collagen and hyaluronic acid, which work together to dampen the physical stresses during pregnancy and development of the baby. Wharton’s Jelly is also an abundant source of mesenchymal stem cells (MSCs) that are captured during pregnancy and are the most potent and effective of all stem cells for anti-aging and regeneration of the human body.
Our Wharton’s Jelly Stem Cells are minimally manipulated stem cells derived from the Wharton’s Jelly of the umbilical cord. A proprietary process is used to preserve the growth and other native characteristics. Our Wharton’s Jelly Stem Cells are 100% pure.
Benefits of Wharton’s Jelly Stem Cells
Wharton’s Jelly Stem Cells are unsurpassed in their ability to:
Regenerate internal organs, regenerate joints, and regain brain function
- Increase metabolic energy through mitochondrial transfer to the patient
- Naturally detect and destroy cancer
Our proprietary Wharton’s Jelly stem cell protocol can restore function of internal organs, regain brain function and eliminated body and joint pain.
Quality & Custody
We take control and custody of the umbilical cord moments after a healthy baby is born. We then transport, process, cryofreeze and deliver the finished cell product directly to local medical professionals that we know and trust. At no point do we permit third parties to take control of our product. Over the years we have found this to theour patients that they are getting the absolute best stem cell product available. We do not purchase umbilical cords from brokers, nor do we ship our cellular products to distributors.
All umbilical cord donors are pre-screened and undergo rigorous and comprehensive testing that includes:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testing
Infectious disease testing is performed at certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.